Antonio F. N.
- Country
- Spain
- Department
- Rheumatology
Research Overview
- Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion
- A Phase I Dose Escalation Study of Bispecific Antibodies in Adult Patients with Lupus Nephritis
- An Open-Label Extension Study to Evaluate Long Term Safety and Efficacy of Tildrakizumab in Patients with Psoriatic Arthritis.
Data & Insights
Has run more than one trial at 299 of 502 partner sites.
Specializations
Rheumatology
The investigator specializes in the treatment and research of psoriatic arthritis, focusing on innovative therapeutic approaches for patients who have not previously received biological treatments.
- Inflammatory Joint Disorders
- Autoimmune Conditions
- Novel Therapeutic Agents
Their work encompasses the evaluation of emerging treatment options for managing active psoriatic arthritis symptoms and disease progression.
Immunology
The investigator's research interests center on immune-mediated inflammatory conditions, with particular attention to the development of targeted therapies for autoimmune arthritis.
- Immune System Modulation
- Treatment-Naive Patients
- Inflammatory Pathways
Their expertise extends to investigating novel therapeutic compounds that target specific immune pathways in inflammatory arthritis.
Clinical Therapeutics
The investigator focuses on advancing therapeutic interventions for chronic inflammatory conditions, particularly in evaluating the effectiveness of new pharmaceutical compounds.
- Treatment Efficacy Assessment
- Patient Response Evaluation
- Therapeutic Innovation
Their research encompasses the evaluation of novel therapeutic agents for patients with active inflammatory joint conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.